Susquehanna Fundamental Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,583
| Closed | -$543K | – | 420 |
|
|
2023
Q2 | $543K | Sell |
2,583
-41,019
| -94% | -$8.62M | 0.02% | 430 |
|
|
2023
Q1 | $8.8M | Sell |
43,602
-31,994
| -42% | -$6.46M | 0.21% | 140 |
|
|
2022
Q4 | $16.5M | Buy |
75,596
+8,783
| +13% | +$1.91M | 0.28% | 101 |
|
|
2022
Q3 | $13.1M | Buy |
+66,813
| New | +$13.1M | 0.22% | 117 |
|
|
2022
Q1 | – | Sell |
-1,036
| Closed | -$390K | – | 1561 |
|
|
2021
Q4 | $390K | Sell |
1,036
-7,324
| -88% | -$2.76M | 0.01% | 1015 |
|
|
2021
Q3 | $3.45M | Sell |
8,360
-7,550
| -47% | -$3.12M | 0.06% | 413 |
|
|
2021
Q2 | $5.89M | Sell |
15,910
-10,393
| -40% | -$3.84M | 0.11% | 260 |
|
|
2021
Q1 | $7.62M | Buy |
26,303
+1,036
| +4% | +$300K | 0.13% | 211 |
|
|
2020
Q4 | $6.31M | Buy |
25,267
+2,237
| +10% | +$559K | 0.12% | 244 |
|
|
2020
Q3 | $5.22M | Buy |
23,030
+12,637
| +122% | +$2.86M | 0.16% | 175 |
|
|
2020
Q2 | $1.81M | Buy |
+10,393
| New | +$1.81M | 0.09% | 308 |
|